VIGL News and Press, Vigil Neuroscience Inc.

2024-06-28 09:15:05 ET Wedbush analyst issues OUTPERFORM recommendation for VIGL on June 28, 2024 07:53AM ET. The previous analyst recommendation was Outperform. VIGL was trading at $4.48 at issue of the analyst recommendation. Historical Analyst Recommendations La...

2024-06-27 07:04:12 ET More on Vigil Neuroscience Biggest stock movers today: BB, MU, and more Augustine Therapeutics raises €17M in series A first closing Seeking Alpha’s Quant Rating on Vigil Neuroscience Historical earnings data for Vigil Neu...

2024-06-27 05:19:29 ET More on related stocks: Micron Technology, Inc. (MU) Q3 2024 Earnings Call Transcript BlackBerry Limited (BB) Q1 2025 Earnings Call Transcript BlackBerry Stock: 4 Considerations Ahead Of Its Q1 2025 Earnings International Paper sinks af...

- Sanofi to invest $40 million at an as-converted price of $7.44 per share of common stock- - Sanofi to receive an exclusive right of first negotiation for license of Company’s small molecule TREM2 agonist program, including VG-3927, currently in phase 1 clinical studies - ...

2024-06-26 09:26:08 ET Read the full article on Seeking Alpha For further details see: Augustine Therapeutics raises EUR 17M in Series A first closing

2024-06-26 03:33:34 ET More on Eli Lilly, Vigil Neuroscience, etc. Eli Lilly: Throwing Its Weight Around - But, For How Long? (Technical Analysis) Eli Lilly: The Party Is Probably Nearing The End Eli Lilly And Alzheimer's Disease: The Paucity Of Progress ResM...

2024-06-11 06:30:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stocks have a unique appeal– one that only strong-stomached, risky-taking investors find appetizing. This is for good reason– these stocks are insanely volatile. By defi...

2024-06-11 06:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stocks are some of the most affordable investments on the market, valued at less than $5. They can hold a unique and intriguing position that can be highly profitable. However, despit...

WATERTOWN, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced management’s participation at two upcoming ...

2024-05-10 15:00:11 ET More on the markets SPY: Growing Signs The Market Is Overbought SPY: The Shrinking Market For U.S. Companies SPY: Stronger Than Ever For the second consecutive week, investors purchase ETFs and conventional funds Earnings estima...